000 01237nam a22003975i 4500
001 978-1-4419-7216-3
003 DE-He213
005 20130515021047.0
007 cr nn 008mamaa
008 101123s2011 xxu| s |||| 0|eng d
020 _a9781441972163
_9978-1-4419-7216-3
024 7 _a10.1007/978-1-4419-7216-3
_2doi
050 4 _aRC261-271
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
082 0 4 _a614.5999
_223
100 1 _aKaye, Stan.
245 1 0 _aEmerging Therapeutic Targets in Ovarian Cancer
_h[electronic resource] /
_cedited by Stan Kaye, Robert Brown, Hani Gabra, Martin Gore.
260 _aNew York, NY :
_bSpringer New York,
_c2011.
300 _bdigital.
650 0 _aMedicine.
650 0 _aOncology.
650 0 _aToxicology.
650 1 4 _aBiomedicine.
650 2 4 _aCancer Research.
650 2 4 _aPharmacology/Toxicology.
700 1 _aBrown, Robert.
700 1 _aGabra, Hani.
700 1 _aGore, Martin.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9781441972156
856 4 0 _uhttp://dx.doi.org/10.1007/978-1-4419-7216-3
912 _aZDB-2-SBL
999 _c73298
_d73298